A password will be e-mailed to you.

Decision made to suspend patent processing for medical cannabis

Tijana Martin / THE CANADIAN PRESS BANGKOK — Thailand’s military government on Monday suspended the licensing of commercial marijuana-based products for medical use amid concern that foreign pharmaceutical companies might try to monopolize the market. Prime Minister Prayuth Chan-ocha’s decree orders the director of the Department of Intellectual Property to invalidate all patent applications for medical marijuana products, declaring that for the time being commercial products from marijuana or having the same molecular structure as the plant are not supported under intellectual property laws. The decree says it will remain in effect until legislation on medical marijuana comes into force. Parliament last month legalized the regulated use of medical marijuana but the legislation must be signed by King Maha Vajiralongkorn to become law. At that point, new applications are expected to be allowed that meet conditions specified under the law. The order was issued under special powers the military government that seized power in 2014 gave itself to implement laws without approval from Parliament. Thailand suspends patent processing for medical cannabis

thumbnail courtesy of thegrowthop.com

Dial-A-Joint.com


No more articles